Home
About
Overview
Sharing Data
ORCID
Help
History (54)
Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancer.
Doing more with less: fluorescence in situ hybridization and gene sequencing assays can be reliably performed on archival stained tumor tissue sections.
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.
Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure.
G48A, a New KRAS Mutation Found in Lung Adenocarcinoma.
See All 54 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
G48A, a New KRAS Mutation Found in Lung Adenocarcinoma.
G48A, a New KRAS Mutation Found in Lung Adenocarcinoma. J Thorac Oncol. 2016 07; 11(7):1170-5.
View in:
PubMed
subject areas
Adenocarcinoma
Adult
Animals
Cells, Cultured
Extracellular Signal-Regulated MAP Kinases
Female
High-Throughput Nucleotide Sequencing
Humans
Lung Neoplasms
Male
Mice
Mutation
NIH 3T3 Cells
Proto-Oncogene Proteins p21(ras)
authors with profiles
Marina Chiara Garassino